Sanara MedTech Inc. (SMTI): Price and Financial Metrics
GET POWR RATINGS... FREE!
SMTI POWR Grades
- Sentiment is the dimension where SMTI ranks best; there it ranks ahead of 99.52% of US stocks.
- SMTI's strongest trending metric is Growth; it's been moving up over the last 178 days.
- SMTI ranks lowest in Value; there it ranks in the 17th percentile.
SMTI Stock Summary
- For SMTI, its debt to operating expenses ratio is greater than that reported by only 6.42% of US equities we're observing.
- Over the past twelve months, SMTI has reported earnings growth of 179.8%, putting it ahead of 91.73% of US stocks in our set.
- As for revenue growth, note that SMTI's revenue has grown 71.51% over the past 12 months; that beats the revenue growth of 89.6% of US companies in our set.
- Stocks that are quantitatively similar to SMTI, based on their financial statements, market capitalization, and price volatility, are VEEE, OTLY, THRN, NAOV, and HNST.
- Visit SMTI's SEC page to see the company's official filings. To visit the company's web site, go to www.wndm.com.
SMTI Valuation Summary
- In comparison to the median Healthcare stock, SMTI's price/sales ratio is 87.23% higher, now standing at 8.8.
- SMTI's EV/EBIT ratio has moved down 23.5 over the prior 243 months.
Below are key valuation metrics over time for SMTI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SMTI | 2023-03-17 | 8.8 | 7.3 | -29.2 | -25.0 |
| SMTI | 2023-03-16 | 9.0 | 7.5 | -29.7 | -25.5 |
| SMTI | 2023-03-15 | 8.9 | 7.3 | -29.2 | -25.0 |
| SMTI | 2023-03-14 | 9.2 | 7.6 | -30.5 | -26.1 |
| SMTI | 2023-03-13 | 9.1 | 7.5 | -29.9 | -25.6 |
| SMTI | 2023-03-10 | 9.0 | 7.4 | -29.5 | -25.3 |
SMTI Growth Metrics
- The 2 year revenue growth rate now stands at 110.44%.
- Its 3 year net cashflow from operations growth rate is now at -13769.68%.
- The 5 year cash and equivalents growth rate now stands at 657.25%.
The table below shows SMTI's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 37.55998 | -6.694212 | -11.39348 |
| 2022-06-30 | 30.33935 | -6.485426 | -11.94339 |
| 2022-03-31 | 26.94571 | -5.6654 | -9.869494 |
| 2021-12-31 | 24.14392 | -4.814526 | -7.921914 |
| 2021-09-30 | 21.89965 | -3.621237 | -4.620099 |
| 2021-06-30 | 20.38203 | -2.898222 | -3.746955 |
SMTI Stock Price Chart Interactive Chart >
SMTI Price/Volume Stats
| Current price | $39.96 | 52-week high | $49.50 |
| Prev. close | $39.75 | 52-week low | $17.41 |
| Day low | $39.00 | Volume | 30,000 |
| Day high | $40.73 | Avg. volume | 12,380 |
| 50-day MA | $42.75 | Dividend yield | N/A |
| 200-day MA | $33.27 | Market Cap | 331.83M |
Sanara MedTech Inc. (SMTI) Company Bio
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Latest SMTI News From Around the Web
Below are the latest news stories about SANARA MEDTECH INC that investors may wish to consider to help them evaluate SMTI as an investment opportunity.
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 ResultsFORT WORTH, TX, March 20, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter and full year ended D |
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Earnings Release and Conference Call DatesFORT WORTH, TX, March 06, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin care markets, announced today details for the release of its results for the quarter and year ended December 31, 20 |
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2022FORT WORTH, TX, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin care markets, announced today certain unaudited preliminary results for the fourth quarter and full-year 2022. Selec |
Sanara MedTech to Participate in Two Upcoming Healthcare ConferencesFORT WORTH, TX, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Zach Fleming, the Company’s Chief Executive Officer, will present at the Piper Sandler 34th Annual Healthcare Conference in New York, New York on Wednesday, November 30, 2022 at 12:30 p.m. ET and will participate in a panel discu |
Sanara MedTech Inc. Announces Third Quarter 2022 ResultsFORT WORTH, TX, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter ended September 30, 2022. Zach Fleming, Sanara's CEO, stated, “The third quarter of 2022 was another revenue record for S |
SMTI Price Returns
| 1-mo | N/A |
| 3-mo | -2.58% |
| 6-mo | 46.32% |
| 1-year | 43.74% |
| 3-year | 295.64% |
| 5-year | 593.75% |
| YTD | -12.18% |
| 2022 | 53.98% |
| 2021 | -40.78% |
| 2020 | 209.94% |
| 2019 | 392.35% |
| 2018 | -45.50% |
Loading social stream, please wait...